Search results
Results from the WOW.Com Content Network
Attention deficit hyperactivity disorder management options are evidence-based practices with established treatment efficacy for ADHD.Approaches that have been evaluated in the management of ADHD symptoms include FDA-approved pharmacologic treatment and other pharmaceutical agents, psychological or behavioral approaches, combined pharmacological and behavioral approaches, cognitive training ...
Attention deficit/ hyperactivity disorder (ADHD) is one of the most prevalent neurological disorders found in children. [3]The ADHD-RS was created by George J. DuPaul, Thomas J. Power, Arthur D. Anastopoulos, and Robert Reid to address the need for an effective evaluation for children and adolescents suspected of having ADHD. [3]
[2] [5] As public awareness of ADHD has increased, epidemiological studies have found a prevalence rate of 4–12% in children of ages 6–12 throughout the United States. Not only is ADHD the most commonly encountered childhood-onset disorder in neurodevelopment, there is also a high comorbidity rate linking ADHD with other behavioral ...
ADDitude magazine is a quarterly consumer publication about attention deficit hyperactivity disorder (ADHD or ADD) owned and operated by WebMD, LLC in New York, NY. It contains feature and service articles about ADD, ADHD and comorbid conditions including depression, anxiety, and learning disabilities like dyslexia.
Attention deficit hyperactivity disorder (ADHD) [1] is a neurodevelopmental disorder characterized by symptoms of inattention, hyperactivity, impulsivity and emotional dysregulation that are excessive and pervasive, impairing in multiple contexts, and developmentally-inappropriate. [9]
The types of special needs vary in severity, and a student with a special need is classified as being a severe case when the student's IQ is between 20 and 35. [1] These students typically need assistance in school, and have different services provided for them to succeed in a different setting.
Attention deficit hyperactivity disorder predominantly inattentive (ADHD-PI or ADHD-I), [3] is one of the three presentations of attention deficit hyperactivity disorder (ADHD). [4] In 1987–1994, there were no subtypes or presentations and thus it was not distinguished from hyperactive ADHD in the Diagnostic and Statistical Manual (DSM-III-R).
This is a list of investigational attention deficit hyperactivity disorder drugs, or drugs that are currently under development for clinical use in the treatment of attention deficit hyperactivity disorder (ADHD) but are not yet approved. Chemical/generic names are listed first, with developmental code names, synonyms, and brand names in ...